You are about to leave www.astellas.com and enter a third-party website. Astellas is not responsible for the content or services on the third-party website.
Would you like to continue?
Astellas has established a Focus Area Approach for our research and development (R&D) strategy. This strategy helps us to build a sustainable, expandable drug discovery approach to develop new platforms, leverage expertise and create innovative therapies.
Our approach combines three core components:
1. Blindness and Regeneration: Helping to free patients from the fear of vision loss and offer the hope of recovery and restored sight.
2. Genetic Regulation: Developing genetic medicines with the potential to deliver transformative VALUE for patients.
3. Immuno-Oncology: Harnessing a deep understanding of cancer immunology to develop the oncology medicines of tomorrow.
4. Targeted Protein Degradation: Targeting harmful proteins to transform the treatment of ‘undruggable’ diseases including cancer and others with high unmet need.
Click below to learn more about each of Astellas' Primary Focuses.